Product Details

dnalife™ Certification Course UK 29th-31st March 2019 ALL 6 NGX tests AND Medcheck (R) included - EARLY BIRD OFFER ENDS - 31st JANUARY 2019


Sample type

Average processing time :
Available sizes
SizeYour price
ex vat $390.00

Nordic Laboratories dnalife® Certification Course

Nutrigenomics has come of age. More and more research is published supporting the fact that our genes, and how they react to our environment, impact how we are able to optimise our health and wellbeing. Nordic Laboratories has a family of genetic tests that can aid clinicians with individualising their patient strategies.

The applications of personalized medicine to patient care include the identification of genetic variants through laboratory tests and/or functional biomarkers for the purpose of designing patient-specific prescriptions for diet, exercise, stress, and environment.[Minich, D.M. and Bland, J.S. Personalized Lifestyle Medicine: Relevance for Nutrition and Lifestyle Recommendations, The Scientific World Journal. Volume 2013, Article ID 129841, 14 pages]

The tests are developed according to rigorous scientific standards. A gene will only be included in a test panel if strong evidence exists for an interaction with the environment, and the effect of the gene variant is in some way modifiable through a nutritional or lifestyle intervention. These findings need to have replicated in a minimum of three studies, and the results published in a peer reviewed journal. Complex as nutrigenomics is, Nordic Laboratories have put together a dnalife™ certification programme aimed at empowering the practitioner as how best to utilise the information gained from these tests.

The study of the relationship between genes and response to drugs has been the subject of intensive research over the past two decades. Robust evidence now exists to support testing under clinical conditions. 


mygeneRx Comprehensive PGX Panel

Pharmacogenomics testing is the most recent addition to the dnalife® portfolio. We analyse genotypes associated with drug responsiveness for cardiovascular disease, psychiatry and pain management, amongst others. Reports provide practitioners with detailed guidelines on gene-drug interactions; highlighting potential side effects, increased toxicity, and lack of efficacy.

mygeneRx is our most comprehensive test, analysing 62 genetic variations associated with cardiovascular disease, pain medication, psychiatric drugs, diabetes medication, infectious disease medications and gastrointestinal drugs.

mygeneRx analyses genetic variants linked to the metabolism of the following drug classes (indicated below their respective medication areas) as well as all of those included in the sub-products mycardioRx, mypsychRx and mypainRx.

Diabetes Medications:


Gastrointestinal Medications:

Proton Pump Inhibitors

Infection Medications:


Rheumatology Medications:

Anti-Gout Agents

Transplantation Medication:


Urological Medications:

5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
Alpha-Blockers for Benign Prostatic Hyperplasia
Antispasmodics for Overactive Bladder
Phosphodiesterase Inhibitors for Erectile Dysfunction

mygeneRx: 62 genetic variations, over 150 drugs


Other info

No Pdf


No Videos

Related products

No Related Products.
Fulfillment managed by:

Nordic Laboratories
Nygade 6, 3 sal
1164 Copenhagen K
+45 33 75 10 00
All payments are processed via ePAY.
ePay / Payment Solutions is PCI certified by VISA / Mastercard, and all communication is encrypted via a secure connection.

© Nordic Group
Powered by Nascent Solutions ©